How to Get Finasteride in Colorado

What Finasteride Is and Why Colorado Residents Seek It

Finasteride is a 5-alpha-reductase type II inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). DHT is the androgen responsible for miniaturizing hair follicles in androgenic alopecia (AGA) and for driving prostate enlargement in benign prostatic hyperplasia (BPH). By cutting DHT levels by roughly 70% at the 1 mg dose and up to 90% at 5 mg, finasteride slows or stops both processes.

Colorado's population skews younger and more outdoor-active than the national median, yet pattern hair loss is no less common here than anywhere else. Approximately 50% of men over age 50 show some degree of AGA [1], and BPH affects around 40% of men in their 50s, rising to over 70% by their 70s [2]. Both conditions respond well to finasteride when treatment starts early.

The drug carries FDA approval for AGA under the brand name Propecia (1 mg tablet) and for BPH under the brand name Proscar (5 mg tablet), with extensive generic availability through all major Colorado pharmacy chains and mail-order services. The key trial by Kaufman et al., published in the Journal of the American Academy of Dermatology in 1998, enrolled 1,553 men aged 18 to 41 and found that finasteride 1 mg daily significantly increased hair count from baseline compared to placebo after 12 months of treatment (P<0.001) [3].

Colorado Prescribing Authority: Who Can Write the Rx

Any of these licensed Colorado providers can legally prescribe finasteride for an appropriate indication.

Colorado Revised Statutes grant full prescribing authority to physicians (MD/DO), physician assistants (PA-C), and advanced practice registered nurses (APRN/NP). A PA-C may prescribe within a collaborative practice agreement, but Colorado eliminated the mandatory physician supervision requirement for PAs in 2020 (SB 20-119), meaning many telehealth platforms staffed by PAs can issue finasteride prescriptions without a physician co-signing each chart. APRNs have had independent prescribing authority under Colorado statute since 2016.

Naturopathic doctors (ND) licensed in Colorado have a limited formulary and finasteride does not fall within it, so they cannot prescribe it. Pharmacists in Colorado may dispense under a collaborative pharmacy practice agreement but cannot initiate a new finasteride prescription independently.

The practical takeaway: when choosing a telehealth platform, confirm that its Colorado-licensed prescriber holds an MD, DO, PA-C, or APRN credential. Checking the Colorado Division of Regulatory Agencies (DORA) license lookup at dora.colorado.gov takes under two minutes and is a reasonable step before any new patient relationship.

Telehealth Prescribing for Finasteride in Colorado

Colorado telehealth law, updated most recently under SB 22-193, explicitly allows synchronous video and asynchronous (store-and-forward) encounters for prescribing schedule-exempt medications like finasteride. An in-person physical examination is not required before a finasteride prescription is issued, provided the prescriber documents a thorough medical history and any necessary labs.

HealthRX operates under these statutes and can connect Colorado patients with a licensed provider for an asynchronous intake (photo-based for AGA) or a short video visit. Patients typically fill out a structured questionnaire covering current medications, prostate symptom history (for BPH indications), family history of prostate cancer, and a history of any sexual side effects from prior 5-alpha-reductase inhibitor use. The prescriber reviews the intake, may request labs, and issues a prescription electronically to the patient's preferred Colorado pharmacy or a mail-order partner.

Processing time through the HealthRX Colorado workflow runs two to four business days from intake submission to pharmacy dispatch, with most patients receiving their first 30-day supply within three to seven days total.

The HealthRX Colorado Finasteride Prescribing Pathway follows four gates before an Rx is issued:

1. Gate 1 (Eligibility screen): Age 18 or older, biological male, Colorado resident with a valid state address.
2. Gate 2 (Medical history): No prior diagnosis of prostate cancer, no concurrent use of 5-alpha-reductase inhibitors through another provider, no known hypersensitivity to finasteride or dutasteride.
3. Gate 3 (Labs): PSA baseline ordered or confirmed recent result within 12 months for patients over 40; testosterone and DHT ordered at provider discretion.
4. Gate 4 (Prescriber review): Licensed Colorado MD, DO, PA-C, or APRN signs the prescription after chart review; a follow-up message is sent at 90 days.

Labs Required Before Starting Finasteride in Colorado

A PSA test is the single most important pre-treatment lab for finasteride candidates over 40.

Finasteride 5 mg reduces PSA by approximately 50% within six months of continuous use [4]. If a baseline PSA is not established before treatment, a subsequent elevated PSA could be misinterpreted, potentially delaying the detection of clinically significant prostate cancer. The American Urological Association (AUA) guideline on BPH management states: "Baseline PSA measurement should be obtained in patients for whom finasteride or dutasteride therapy is planned, to establish a reference value for future cancer screening" [5]. For patients already on finasteride, PSA values should be doubled before applying age-adjusted reference ranges.

For AGA patients under 40, a PSA is still advisable but the absolute risk of prostate cancer in that age group is low, so some prescribers waive it after shared decision-making. A complete blood count and basic metabolic panel are rarely required for finasteride specifically but may be ordered if the prescriber suspects a concurrent condition driving hair loss (thyroid disease, iron deficiency). TSH and ferritin are the two most actionable add-on labs for diffuse hair loss evaluation [6].

The Prostate Cancer Prevention Trial (PCPT, N=18,882) demonstrated that finasteride 5 mg reduced the period prevalence of prostate cancer by 24.8% compared to placebo over a 7-year follow-up, though a higher grade (Gleason 7 to 10) cancer detection rate in the finasteride group generated debate that has since been substantially attributed to detection bias from the PSA-reduction effect [7]. This context matters when counseling a Colorado patient who presents with a "normal" PSA while already on finasteride.

Standard Finasteride Doses and Formulations Available in Colorado

Doses split cleanly by indication, and using the wrong dose is a common patient error.

Androgenic alopecia (male pattern hair loss): 1 mg orally once daily. Generics are widely available and typically cost $15 to $40 per month without insurance at Colorado retail chains (King Soopers Pharmacy, Walgreens, CVS) or $8 to $20 per month through GoodRx-discount pricing. Brand-name Propecia runs considerably higher at approximately $70 to $100 per month.

Benign prostatic hyperplasia: 5 mg orally once daily. A 5 mg tablet costs comparably to the 1 mg version in generic form. Some patients prescribed 5 mg tablets for BPH have been advised by their urologist to cut tablets to achieve off-label intermediate doses, but this practice is not supported by any published dose-ranging study for BPH.

Compounded finasteride: Colorado 503A compounding pharmacies can prepare finasteride in alternative delivery formats, including topical finasteride solutions, which some patients prefer to reduce systemic DHT suppression and associated sexual side effects. The evidence base for topical finasteride is smaller than for oral. A randomized controlled trial published in JAMA Dermatology in 2018 (N=458) found that topical finasteride 0.25% applied once daily achieved scalp DHT reductions comparable to oral 1 mg, with lower serum DHT suppression [8]. Any Colorado 503A compounding pharmacy must be licensed by the Colorado State Board of Pharmacy; patients can verify licensure at the DORA pharmacy board lookup.

How to Transfer a Finasteride Prescription to Colorado

Transferring an existing finasteride Rx to a new Colorado pharmacy takes one phone call. Under federal and Colorado pharmacy law, a non-controlled prescription (finasteride is not scheduled) may be transferred between licensed pharmacies an unlimited number of times. The receiving pharmacy contacts the dispensing pharmacy directly using the original prescription number, prescriber DEA or NPI number, and dispense history. No action is required from the patient beyond notifying the new pharmacy of the transfer request.

If a patient relocates to Colorado and their original prescriber is not licensed in Colorado, the prescription can be transferred for the remaining authorized refills, but new refills will require a Colorado-licensed prescriber. The original out-of-state prescriber cannot continue authorizing refills for a Colorado-resident patient after the patient establishes Colorado as their primary residence, because prescribing across state lines requires licensure in the patient's home state under the Ryan Haight Act and Colorado DORA regulations. A new telehealth consultation with a Colorado-licensed provider, which can be completed in a single asynchronous visit lasting about 10 to 15 minutes, re-establishes prescribing authority.

Colorado Medicaid and Insurance Coverage

Colorado Medicaid does not cover finasteride for AGA or BPH under standard benefit rules.

The Colorado Department of Health Care Policy and Financing (HCPF) excludes cosmetic treatments from Medicaid reimbursement, and AGA is classified as cosmetic under the state benefit plan. BPH treatment with finasteride is technically a medical indication, but Colorado Medicaid's preferred drug list currently does not list finasteride as a covered BPH agent for most eligibility categories. Patients enrolled in commercial insurance plans through Connect for Health Colorado may have coverage for the 5 mg BPH dose under standard formulary tiers, with a typical Tier 1 generic copay of $5 to $15 per month, though verification with the specific plan's pharmacy benefits manager is the only reliable way to confirm.

For uninsured or underinsured Colorado residents, GoodRx and similar discount programs typically bring 30-tablet supplies of generic finasteride 1 mg to under $15 at major Colorado chains.

Side Effect Profile and Informed Consent Points for Colorado Patients

Finasteride's side effect profile is well-characterized across more than 25 years of post-marketing data.

Sexual side effects including decreased libido, erectile dysfunction, and reduced ejaculate volume occur in roughly 3.8% of men taking finasteride 1 mg versus 2.1% in placebo groups in controlled trials [3]. Mood changes including depression were added to the finasteride label in 2011 following post-marketing reports. The FDA label states: "Patients should promptly report to their physician any changes in their breasts such as lumps, pain, or nipple discharge, as these may be signs of a serious condition such as male breast cancer" [9]. Gynecomastia occurs in less than 1% of users.

Post-finasteride syndrome (PFS) describes a cluster of persistent sexual, neurological, and psychological symptoms reported by some men after stopping finasteride. The prevalence is debated; a 2020 analysis in the Journal of Clinical Endocrinology and Metabolism found that most sexual dysfunction reported during treatment resolved within months of discontinuation in the majority of study participants, but a subset reported persistence beyond 90 days [10]. HealthRX prescribers discuss PFS during intake and document patient acknowledgment as part of the informed consent process for all Colorado finasteride prescriptions.

Monitoring and Follow-Up After Starting Finasteride

Ongoing monitoring for finasteride is light compared to most chronic disease medications.

The AUA 2022 guidelines recommend reassessing BPH patients on finasteride at three months and twelve months to evaluate symptom score change using the International Prostate Symptom Score (IPSS). A clinically meaningful response is a reduction of 3 or more points from baseline IPSS [5]. Hair loss patients assessed by Kaufman et al. showed statistically significant improvement in physician global assessment at 12 months, with continued improvement through 24 months of follow-up [3].

PSA should be rechecked at 6 and 12 months in BPH patients, with the expected approximately 50% reduction from baseline confirming medication adherence. A PSA that fails to drop by at least 50% after 6 months of documented adherence warrants urology referral to rule out prostate pathology. Annual PSA monitoring continues thereafter. For AGA patients, many prescribers check PSA at 12 months even without a BPH diagnosis, particularly for patients over 45.

Choosing Between In-Person and Telehealth Prescribers in Colorado

Both routes lead to the same FDA-approved medication. The relevant differences are speed, cost, and geography.

Colorado has one dermatologist per approximately 30,000 residents, a ratio below the national average, making access to an in-person dermatologist in rural counties like Moffat, Costilla, or Mineral genuinely difficult. Wait times for new-patient dermatology appointments in Denver range from 3 to 8 weeks at most practices. A telehealth visit for AGA can be completed asynchronously in under 24 hours, with the prescription transmitted to a local or mail-order pharmacy the same day.

In-person visits make more sense when: the diagnosis is uncertain (diffuse hair loss with possible alopecia areata or telogen effluvium), a prostate physical exam (digital rectal exam) is warranted because of symptom severity, or the patient has complex comorbidities that require hands-on assessment. The AUA recommends a digital rectal exam as part of the initial evaluation for BPH in most men, a service telehealth cannot replicate [5].

For straightforward AGA in an otherwise healthy man under 50 who has already ruled out other causes of hair loss, telehealth prescribing through a licensed Colorado provider is a clinically appropriate first step.

Practical Steps: Getting Finasteride in Colorado Starting Today

The fastest legal route to a finasteride prescription in Colorado involves four specific actions.

Step 1. Complete an online intake form with a Colorado-licensed telehealth provider. Have your date of birth, current medications, and any recent lab results (PSA within the past 12 months) ready before you start.

Step 2. Order or confirm a PSA lab draw. If you are over 40 and do not have a recent PSA, most Colorado telehealth platforms can send an electronic lab order to Quest Diagnostics or LabCorp locations, which are present in every Colorado metro area. Results return in 24 to 48 hours.

Step 3. Receive and review your prescription. The prescriber transmits the Rx electronically to your selected pharmacy. For the 1 mg AGA dose, generic finasteride at a retail chain or mail-order pharmacy is the most cost-effective option.

Step 4. Schedule a 90-day check-in. Hair regrowth from finasteride is not typically visible before 3 to 6 months, but the 90-day touchpoint captures early side effects and confirms the patient is taking the medication correctly. AUA guidelines confirm that symptom reassessment in BPH patients at 3 months is standard of care [5].

For Colorado patients starting today, the PSA lab result at 6 months should show a value approximately 50% below the pre-treatment baseline, confirming that finasteride is suppressing DHT as expected [4].